机构：[1]Department of Clinical Pharmacology, The Second Affiliated Hospital of Soochow University, Suzhou 215004[2]Department of Pharmaceutics, Soochow University Affiliated Children’s Hospital, Suzhou 215003[3]Suzhou Institute for Food and Drug Control, Suzhou 215104
第一作者机构：[1]Department of Clinical Pharmacology, The Second Affiliated Hospital of Soochow University, Suzhou 215004
通讯作者：
通讯机构：[1]Department of Clinical Pharmacology, The Second Affiliated Hospital of Soochow University, Suzhou 215004
推荐引用方式(GB/T 7714)：
Yunli Yu,Quanying Zhang,Wenjun Xu,et al.Population pharmacokinetic modeling of oxcarbazepine active metabolite in Chinese patients with epilepsy (vol 41, pg 345, 2016)[J].EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS.2017,42(1):171.doi:10.1007/s13318-016-0379-5.
APA：
Yunli Yu,Quanying Zhang,Wenjun Xu,Chengzhe Lv&Gang Hao.(2017).Population pharmacokinetic modeling of oxcarbazepine active metabolite in Chinese patients with epilepsy (vol 41, pg 345, 2016).EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS,42,(1)
MLA：
Yunli Yu,et al."Population pharmacokinetic modeling of oxcarbazepine active metabolite in Chinese patients with epilepsy (vol 41, pg 345, 2016)".EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS 42..1(2017):171
